SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-20-016858
Filing Date
2020-07-07
Accepted
2020-07-07 15:37:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea123911-sc13gl2cap_propanc.htm SC 13G 37471
  Complete submission text file 0001213900-20-016858.txt   39053
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Subject) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-87562 | Film No.: 201016078
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8900 STATELINE ROAD SUITE 410 LEAWOOD KS 66206
Business Address 8900 STATELINE ROAD SUITE 410 LEAWOOD KS 66206 312-973-1180
L2 Capital, LLC (Filed by) CIK: 0001694707 (see all company filings)

IRS No.: 814411195 | State of Incorp.: KS | Fiscal Year End: 1231
Type: SC 13G